The Importance of Enhanced Radiation Protections in Cath Labs
In this week’s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR). He follows this with an examination of a new consensus statement about enhanced radiation protection in cath labs, then offers a perspective on particulate matter in the environment and increased coronary heart disease risk. Finally, Dr. Eagle provides an analysis of the SUMMIT Trial, showing the benefit of tirzepatide for heart failure with preserved ejection fraction (HFpEF) both in women and men.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Acute Heart Failure, Interventions and Imaging, Echocardiography/Ultrasound, Nuclear Imaging, Acute Coronary Syndromes
Keywords: STS/ACC TVT Registry, National Cardiovascular Data Registries, Body Mass Index, Transcatheter Aortic Valve Replacement, Registries, Radiation Protection, Radiology, Interventional, Occupational Exposure, Laboratory Personnel, Electrophysiology, Echocardiography, Fluoroscopy, Anterior Wall Myocardial Infarction, Risk Factors, Adiposity, Heart Failure, Sex Characteristics, Obesity
